Alon Lazarus Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alon Lazarus.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alon Lazarus. Alon Lazarus is Director in Keros Therapeutics, Inc. ($KROS) and Director in Werewolf Therapeutics, Inc. ($HOWL).
Latest Insider Trading Transactions of Alon Lazarus
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | HOWL | Werewolf Therapeut ... | Lazarus Alon | Director | Option Exercise | C | 0.00 | 3,560,551 | 0 | 0 | |
| May 04 2021 | HOWL | Werewolf Therapeut ... | Lazarus Alon | Director | Option Exercise | C | 0.00 | 10,714,284 | 0 | 0 | |
| May 04 2021 | HOWL | Werewolf Therapeut ... | Lazarus Alon | Director | Option Exercise | A | 16.00 | 23,200 | 371,200 | 23,200 | |
| May 04 2021 | HOWL | Werewolf Therapeut ... | Lazarus Alon | Director | Option Exercise | P | 0.00 | 3,560,551 | 0 | 3,560,551 | |
| May 04 2021 | HOWL | Werewolf Therapeut ... | Lazarus Alon | Director | Buy | P | 16.00 | 400,000 | 6,400,000 | 2,046,634 | 1.6 M to 2 M (+24.29 %) |
| May 04 2021 | HOWL | Werewolf Therapeut ... | Lazarus Alon | Director | Buy | C | 0.00 | 410,717 | 0 | 1,646,634 | 1.2 M to 1.6 M (+33.23 %) |
| May 04 2021 | HOWL | Werewolf Therapeut ... | Lazarus Alon | Director | Buy | C | 0.00 | 1,235,917 | 0 | 1,235,917 | 0 to 1.2 M |
| Apr 13 2020 | KROS | Keros Therapeutics ... | Lazarus Alon | Director | Option Exercise | C | 0.00 | 167,537 | 0 | 0 | |
| Apr 13 2020 | KROS | Keros Therapeutics ... | Lazarus Alon | Director | Option Exercise | C | 0.00 | 343,270 | 0 | 0 | |
| Apr 13 2020 | KROS | Keros Therapeutics ... | Lazarus Alon | Director | Option Exercise | C | 0.00 | 1,382,295 | 0 | 0 | |
| Apr 13 2020 | KROS | Keros Therapeutics ... | Lazarus Alon | Director | Buy | P | 16.00 | 120,000 | 1,920,000 | 2,013,102 | 1.9 M to 2 M (+6.34 %) |
| Apr 13 2020 | KROS | Keros Therapeutics ... | Lazarus Alon | Director | Buy | C | 0.00 | 167,537 | 0 | 1,893,102 | 1.7 M to 1.9 M (+9.71 %) |
| Apr 13 2020 | KROS | Keros Therapeutics ... | Lazarus Alon | Director | Buy | C | 0.00 | 343,270 | 0 | 1,725,565 | 1.4 M to 1.7 M (+24.83 %) |
| Apr 13 2020 | KROS | Keros Therapeutics ... | Lazarus Alon | Director | Buy | C | 0.00 | 1,382,295 | 0 | 1,382,295 | 0 to 1.4 M |
Page: 1